Translations:SGLT2 inhibitor/12/en
Jump to navigation
Jump to search
In the FDA Adverse Event Reporting System an increase was reported in events of acute kidney injury associated with SGLT2 inhibitors, though data from clinical trials actually showed a reduction in such events with SGLT-2 treatment.